Experimental stroke drug PP-007 passes early safety check in 24 patients
Disease control
Completed
This early-stage study tested the safety of an experimental drug called PP-007 in 24 people having an acute ischemic stroke (a stroke caused by a blood clot). Participants received two doses of the drug along with standard treatments like clot-busting medicine or clot removal. Th…
Phase: PHASE1 • Sponsor: Prolong Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:12 UTC